Rule reference

Drugs and Cosmetics Act — Retail / Wholesale Drug Sale

RULE_DRUGS_ACT

Plain-language overview for organisations checking what may apply to them. This is a reference guide — not a substitute for the official gazette or legal advice.

← All compliance rulesWhat applies to my organisation? →

Drugs and Cosmetics Act — Retail / Wholesale Drug Sale (RULE_DRUGS_ACT)

Reference only — not legal advice. This page is EarthReheal WasteLedger's plain-language interpretation of the rule, written to help organisations understand what may apply to them. It can be incomplete or inaccurate. Always read the official gazette notification or statute, and confirm with your regulator or a qualified adviser, before relying on it for compliance decisions.

Quick Summary

EarthReheal WasteLedger's RULE_DRUGS_ACT covers pharmacy / medical-store licensing under the Drugs and Cosmetics Act, 1940 and Drugs Rules, 1945 for retail and wholesale sale of drugs — including prescription discipline for Schedule H / H1 / X — as administered by the State Licensing Authority / State Drug Controller (FDA). It is distinct from EarthReheal WasteLedger's bundled hospital narcotics track `RULE_DRUGS_NDPS` (Essential Narcotic Drugs / RMI under the NDPS Act) and from blood-bank manufacturing licences (`RULE_DRUGS_BLOOD_LICENSE`) and cosmetics (`RULE_DRUGS_COSMETICS`). Sale without a valid licence is an offence under the Act.

What This Rule Is

Full name: Drugs and Cosmetics Act, 1940; Drugs and Cosmetics Rules, 1945 (as amended) — sale-of-drugs chapters.

Issuing authority: Central Act/Rules; licences granted by State Licensing Authorities.

Licence forms (current CDSCO Drugs Rules text — Rule 61):

  • Drugs other than Schedules C, C(1) and X — retail/wholesale/restricted: Form 20 / 20A / 20B as applicable.
  • Schedules C and C(1) excluding X — Form 21 / 21A / 21B.
  • Schedule X — retail/wholesale: Form 20F / 20G.

Application: commonly Form 19 (and related forms) to the State Licensing Authority, with premises, qualified person / registered pharmacist evidence, and fees (Lawrbit and State FDA SOPs — confirm current fee/area norms with your State FDA).

Conditions of licences: primarily Rule 65 (and related rules) — prescription supply records for Schedule H/H1/X, purchase/sale records, storage, presence of qualified person, etc. Schedule H1 register duties (separate register; retain three years) were introduced via G.S.R. 588(E), 30 August 2013 (also noted in RULE_DRUGS_NDPS Bible).

Note on "Rule 67": Briefing materials sometimes shorthand retail/wholesale as "Rule 67." In the current CDSCO-consolidated Drugs Rules PDF reviewed, Rule 61 carries forms of sale licences and Rule 65 the general conditions; Rule 67-series provisions address other sale categories (e.g., Homoeopathic 67C in older mirrors). if your State circular still cites "Rule 67" for allopathic retail, read it as a possible older citation path — verify against the State FDA's current rule extract rather than assuming a single national Rule 67 allopathic retail section.

Schedule H / X (high level):

  • Schedule H / H1: prescription-only supply; H1 has enhanced register and labelling (red Rx / warning box).
  • Schedule X: stricter retail/wholesale forms (20F/20G); prescriptions retained (commonly two years per Rule 65 practice summaries) and bound registers for supplies.

Policy purpose: ensure drugs are sold only from licensed premises by qualified persons, with auditable prescription and stock controls — especially for habit-forming and high-risk schedules.

Who This Applies To

Retail pharmacies / medical stores, wholesale drug distributors, and any premises stocking drugs for sale/distribution. Dental clinics or other clinics that retail drugs may need appropriate sale licences — confirm with State FDA. EarthReheal WasteLedger pharmacy org pack treats this as mandatory; dental packs may gate on on-site expired-drug handling.

*Does not by itself authorise: NDPS Essential Narcotic Drugs institutional possession (RULE_DRUGS_NDPS), blood-bank operations (RULE_DRUGS_BLOOD_LICENSE), or cosmetics manufacture (RULE_DRUGS_COSMETICS*).

State-Level Variations

Central Rules; State FDA portals, fees, inspection SOPs, and additional circulars differ. Some States run fully online licensing; others hybrid. Multi-state chains need per-State, per-premises licences.

Compliance Requirements — What You Actually Have to Do

1. Obtain the correct Forms 20/21/20F/20G (etc.) licences before stocking/selling; display licences as required.

2. Engage a registered pharmacist / qualified person as mandated for the licence category.

3. Enforce Schedule H/H1/X prescription rules; maintain H1 and X registers for the retention periods.

4. Maintain purchase and sale records; enable inspector access.

5. Renew licences on the State validity cycle; intimate changes of premises, partners, or competent person.

6. Dispose of expired drugs via authorised reverse-supply / BMW pathways as applicable — do not dump in municipal waste (cross-ref BMW / NDPS Bibles where relevant).

Penalties & Enforcement

Sale without licence, spurious/adulterated drugs, and Schedule violations attract prosecution under the Drugs and Cosmetics Act (imprisonment and fines varying by offence section — read current Act). State FDA may suspend/cancel licences. Treat this as high-severity regulatory risk.

Frequently Asked Questions

Q: Is RULE_DRUGS_ACT the same as RULE_DRUGS_NDPS? A: No. This rule is Drugs Act sale licensing + Schedule H/X discipline. RULE_DRUGS_NDPS adds NDPS/RMI controls for Essential Narcotic Drugs.

Q: Do we need both retail and wholesale licences? A: If you both retail to patients and wholesale to other dealers, State FDA practice typically requires the matching form set for each activity/premises — confirm before operating dual channels from one shop.

Q: Hospital pharmacy — sale licence or something else? A: Hospital dispensing often uses State FDA hospital/pharmacy licence categories under the same Rules family; exact form numbers vary — ask the State Drug Controller. END stocking still needs RULE_DRUGS_NDPS analysis.

Government / Official Sources

Related Rules

  • RULE_DRUGS_NDPS — narcotic/psychotropic RMI track (distinct).
  • RULE_DRUGS_BLOOD_LICENSE — blood centre manufacturing licence.
  • RULE_DRUGS_COSMETICS — Cosmetics Rules 2020.
  • RULE_BMW_2016 — expired/discarded medicine disposal pathways.

Additional Reference Content

Secondary sources (law firm explainers, news, consultancy blogs, or official-body sites on a non-.gov.in/.nic.in domain) — useful context, not primary legal authority.

Looking for which rules apply to your organisation type? See the interactive coverage picker on the compliance coverage page.